<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Q&#038;A: US Food and Drug Administration (FDA) approves MRD as a basis for accelerated approval in myeloma	</title>
	<atom:link href="https://www.mpeurope.org/qa-us-food-and-drug-administration-fda-approves-mrd-as-a-basis-for-accelerated-approval-in-myeloma/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.mpeurope.org/qa-us-food-and-drug-administration-fda-approves-mrd-as-a-basis-for-accelerated-approval-in-myeloma/</link>
	<description></description>
	<lastBuildDate>Fri, 23 Jan 2026 12:08:10 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>
</channel>
</rss>
